Homocysteine and cardiovascular disease - Is HDL the link?

被引：29

作者：

Barter, Philip J. ^{[1
]}

Rye, Kerry-Anne ^{[1
]}

机构：

[1] Heart Res Inst, Camperdown, NSW 2050, Australia

来源：

CIRCULATION RESEARCH | 2006年 / 99卷 / 06期

关键词：

homocysteine; cardiovascular; apoA-I; HDL;

D O I：

10.1161/01.RES.0000243583.39694.1f

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：565 / 566

页数：2

共 21 条

[1] REGRESSION OF ATHEROSCLEROTIC LESIONS BY HIGH-DENSITY-LIPOPROTEIN PLASMA FRACTION IN THE CHOLESTEROL-FED RABBIT [J].

BADIMON, JJ ;

BADIMON, L ;

FUSTER, V .

JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (04) :1234-1241

[2] Antiinflammatory properties of HDL [J].

Barter, PJ ;

Nicholls, S ;

Rye, KA ;

Anantharamaiah, GM ;

Navab, M ;

Fogelman, AM .

CIRCULATION RESEARCH, 2004, 95 (08) :764-772

[3] High density lipoproteins and coronary heart disease [J].

Barter, PJ ;

Rye, KA .

ATHEROSCLEROSIS, 1996, 121 (01) :1-12

[4] Homocysteine lowering and cardiovascular events after acute myocardial infarction [J].

Bonaa, KH ;

Njolstad, I ;

Ueland, PM ;

Schirmer, H ;

Tverdal, A ;

Steigen, T ;

Wang, H ;

Nordrehaug, JE ;

Arnesen, E ;

Rasmussen, K .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (15) :1578-1588

[5] Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease [J].

Brown, BG ;

Zhao, XQ ;

Chait, A ;

Fisher, LD ;

Cheung, MC ;

Morse, JS ;

Dowdy, AA ;

Marino, EK ;

Bolson, EL ;

Alaupovic, P ;

Frohlich, J ;

Albers, JJ ;

Serafini, L ;

Huss-Frechette, E ;

Wang, S ;

DeAngelis, D ;

Dodek, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (22) :1583-1592

[6] INCIDENCE OF CORONARY HEART-DISEASE AND LIPOPROTEIN CHOLESTEROL LEVELS - THE FRAMINGHAM-STUDY [J].

CASTELLI, WP ;

GARRISON, RJ ;

WILSON, PWF ;

ABBOTT, RD ;

KALOUSDIAN, S ;

KANNEL, WB .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20) :2835-2838

[7] Homocysteine and risk of ischemic heart disease and stroke -: A meta-analysis [J].

Clarke, R ;

Collins, R ;

Lewington, S ;

Donald, A ;

Alfthan, G ;

Tuomilehto, J ;

Arnesen, E ;

Bonaa, K ;

Blacher, J ;

Boers, GHJ ;

Bostom, A ;

Bots, ML ;

Grobee, DE ;

Brattström, L ;

Breteler, MMB ;

Hofman, A ;

Chambers, JC ;

Kooner, JS ;

Coull, BM ;

Evans, RW ;

Kuller, LH ;

Evers, S ;

Folsom, AR ;

Freyburger, G ;

Parrot, F ;

Genst, J ;

Dalery, K ;

Graham, IM ;

Daly, L ;

Hoogeveen, EK ;

Kostense, PJ ;

Stehouwer, CDA ;

Hopknis, PN ;

Jacques, P ;

Selhub, J ;

Luft, FC ;

Jungers, P ;

Lindgren, A ;

Lolin, YI ;

Loehrer, F ;

Fowler, B ;

Mansoor, MA ;

Malinow, MR ;

Ducimetiere, P ;

Nygard, O ;

Refsum, H ;

Vollset, SE ;

Ueland, PM ;

Omenn, GS ;

Beresford, SAA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (16) :2015-2022

[8] HIGH-DENSITY LIPOPROTEIN AS A PROTECTIVE FACTOR AGAINST CORONARY HEART-DISEASE - FRAMINGHAM STUDY [J].

GORDON, T ;

CASTELLI, WP ;

HJORTLAND, MC ;

KANNEL, WB ;

DAWBER, TR .

AMERICAN JOURNAL OF MEDICINE, 1977, 62 (05) :707-714

[9] Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study):: randomised controlled trial [J].

Keech, A ;

Simes, RJ ;

Barter, P ;

Best, J ;

Scott, R ;

Taskinen, MR ;

Forder, P ;

Pillai, A ;

Davis, T ;

Glasziou, P ;

Drury, P ;

Kesäniemi, YA ;

Sullivan, D ;

Hunt, D ;

Colman, P ;

d'Emden, M ;

Whiting, M ;

Ehnholm, C ;

Laakso, M .

LANCET, 2005, 366 (9500) :1849-1861

[10] Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I protein synthesis and enhancing HDL cholesterol clearance [J].

Liao, Dan ;

Tan, Hongmei ;

Hui, Rutai ;

Li, Zhaohui ;

Jiang, Xiaohua ;

Gaubatz, John ;

Yang, Fan ;

Durante, William ;

Chan, Lawrence ;

Schafer, Andrew I. ;

Pownall, Henry J. ;

Yang, Xiaofeng ;

Wang, Hong .

CIRCULATION RESEARCH, 2006, 99 (06) :598-606

← 1 2 3 →